Publicaciones en colaboración con investigadores/as de Clínica Universitaria de Navarra (44)

2024

  1. Clusters of cognitive performance predict long-term cognitive impairment in elderly patients with subjective memory complaints and healthy controls

    Alzheimer's and Dementia

2013

  1. Subthalamic 6-OHDA-induced lesion attenuates levodopa-induced dyskinesias in the rat model of Parkinson's disease

    Experimental Neurology, Vol. 250, pp. 304-312

  2. l-dopa-induced dyskinesias in unilateral 6-hydroxydopamine-lesioned rats are not modified by excitotoxic lesion of the entopeduncular nucleus and substantia nigra pars reticulata

    Synapse, Vol. 67, Núm. 7, pp. 407-414

2012

  1. Hardware complications in deep brain stimulation: Electrode impedance and loss of clinical benefit

    Parkinsonism and Related Disorders, Vol. 18, Núm. 6, pp. 765-769

2011

  1. Deficits in inhibitory control and conflict resolution on cognitive and motor tasks in Parkinson's disease

    Experimental Brain Research, Vol. 212, Núm. 3, pp. 371-384

2010

  1. Chaperone-mediated autophagy markers in Parkinson disease brains

    Archives of Neurology, Vol. 67, Núm. 12, pp. 1464-1472

  2. Cognitive and neuropsychiatric effects of subthalamotomy for Parkinson's disease

    Parkinsonism and Related Disorders, Vol. 16, Núm. 8, pp. 535-539

  3. Efficacy and safety of pallidal stimulation in primary dystonia: Results of the Spanish multicentric study

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 81, Núm. 1, pp. 65-69

  4. The pathophysiological basis of sensory disturbances in Parkinson's disease

    Journal of the Neurological Sciences, Vol. 289, Núm. 1-2, pp. 60-65

2009

  1. Critical review of the subthalamic stimulation in Parkinson's disease

    Neurocirugia, Vol. 20, Núm. 6, pp. 521-532

  2. Homocysteine and cognitive impairment in Parkinson's disease: A biochemical, neuroimaging, and genetic study

    Movement Disorders, Vol. 24, Núm. 10, pp. 1437-1444

  3. Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms

    The Lancet Neurology, Vol. 8, Núm. 12, pp. 1128-1139

  4. Local administration of sarizotan into the subthalamic nucleus attenuates levodopa-induced dyskinesias in 6-OHDA-lesioned rats

    Psychopharmacology, Vol. 204, Núm. 2, pp. 241-250

  5. Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease

    Movement Disorders, Vol. 24, Núm. 8, pp. 1154-1161

2008

  1. Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study

    Movement Disorders, Vol. 23, Núm. 8, pp. 1130-1136

  2. Entacapone potentiates the long-duration response but does not normalize levodopa-induced molecular changes

    Neurobiology of Disease, Vol. 32, Núm. 3, pp. 340-348

  3. Functional organization of the basal ganglia: Therapeutic implications for Parkinson's disease

    Movement Disorders, Vol. 23, Núm. SUPPL. 3

  4. Lesion of the centromedian thalamic nucleus in MPTP-treated monkeys

    Movement Disorders, Vol. 23, Núm. 5, pp. 708-715

  5. Neuronal activity of the red nucleus in Parkinson's disease

    Movement Disorders, Vol. 23, Núm. 6, pp. 908-911

  6. Successful thalamic deep brain stimulation for orthostatic tremor

    Movement Disorders, Vol. 23, Núm. 13, pp. 1808-1811